Global Semaglutide Market Growth 2022-2028
- LP 4799821
- 74 Pages
- January 2022
- Pharmaceuticals
The United States Semaglutide market is expected at value of US$ million in 2021 and grow at approximately % CAGR during review period. China constitutes a % market for the global Semaglutide market, reaching US$ million by the year 2028. As for the Europe Semaglutide landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period. In APAC, the growth rates of other notable markets (Japan and South Korea) are projected to be at % and % respectively for the next 5-year period.
Global main Semaglutide players cover Novo Nordisk, , , and , etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.
This report presents a comprehensive overview, market shares, and growth opportunities of Semaglutide market by product type, application, key manufacturers and key regions and countries.
Segmentation by type: breakdown data from 2017 to 2022, in Section 2.3; and forecast to 2028 in section 12.6
Injection
Oral
Segmentation by application: breakdown data from 2017 to 2022, in Section 2.4; and forecast to 2028 in section 12.7.
Hospital
Clinic
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the prominent manufacturers in this market, include
Novo Nordisk
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Semaglutide Annual Sales 2017-2028
2.1.2 World Current & Future Analysis for Semaglutide by Geographic Region, 2017, 2022 & 2028
2.1.3 World Current & Future Analysis for Semaglutide by Country/Region, 2017, 2022 & 2028
2.2 Semaglutide Segment by Type
2.2.1 Injection
2.2.2 Oral
2.3 Semaglutide Sales by Type
2.3.1 Global Semaglutide Sales Market Share by Type (2017-2022)
2.3.2 Global Semaglutide Revenue and Market Share by Type (2017-2022)
2.3.3 Global Semaglutide Sale Price by Type (2017-2022)
2.4 Semaglutide Segment by Application
2.4.1 Hospital
2.4.2 Clinic
2.5 Semaglutide Sales by Application
2.5.1 Global Semaglutide Sale Market Share by Application (2017-2022)
2.5.2 Global Semaglutide Revenue and Market Share by Application (2017-2022)
2.5.3 Global Semaglutide Sale Price by Application (2017-2022)
3 Global Semaglutide by Company
3.1 Global Semaglutide Breakdown Data by Company
3.1.1 Global Semaglutide Annual Sales by Company (2020-2022)
3.1.2 Global Semaglutide Sales Market Share by Company (2020-2022)
3.2 Global Semaglutide Annual Revenue by Company (2020-2022)
3.2.1 Global Semaglutide Revenue by Company (2020-2022)
3.2.2 Global Semaglutide Revenue Market Share by Company (2020-2022)
3.3 Global Semaglutide Sale Price by Company
3.4 Key Manufacturers Semaglutide Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Semaglutide Product Location Distribution
3.4.2 Players Semaglutide Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 World Historic Review for Semaglutide by Geographic Region
4.1 World Historic Semaglutide Market Size by Geographic Region (2017-2022)
4.1.1 Global Semaglutide Annual Sales by Geographic Region (2017-2022)
4.1.2 Global Semaglutide Annual Revenue by Geographic Region
4.2 World Historic Semaglutide Market Size by Country/Region (2017-2022)
4.2.1 Global Semaglutide Annual Sales by Country/Region (2017-2022)
4.2.2 Global Semaglutide Annual Revenue by Country/Region
4.3 Americas Semaglutide Sales Growth
4.4 APAC Semaglutide Sales Growth
4.5 Europe Semaglutide Sales Growth
4.6 Middle East & Africa Semaglutide Sales Growth
5 Americas
5.1 Americas Semaglutide Sales by Country
5.1.1 Americas Semaglutide Sales by Country (2017-2022)
5.1.2 Americas Semaglutide Revenue by Country (2017-2022)
5.2 Americas Semaglutide Sales by Type
5.3 Americas Semaglutide Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Semaglutide Sales by Region
6.1.1 APAC Semaglutide Sales by Region (2017-2022)
6.1.2 APAC Semaglutide Revenue by Region (2017-2022)
6.2 APAC Semaglutide Sales by Type
6.3 APAC Semaglutide Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 Europe
7.1 Europe Semaglutide by Country
7.1.1 Europe Semaglutide Sales by Country (2017-2022)
7.1.2 Europe Semaglutide Revenue by Country (2017-2022)
7.2 Europe Semaglutide Sales by Type
7.3 Europe Semaglutide Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Semaglutide by Country
8.1.1 Middle East & Africa Semaglutide Sales by Country (2017-2022)
8.1.2 Middle East & Africa Semaglutide Revenue by Country (2017-2022)
8.2 Middle East & Africa Semaglutide Sales by Type
8.3 Middle East & Africa Semaglutide Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Semaglutide
10.3 Manufacturing Process Analysis of Semaglutide
10.4 Industry Chain Structure of Semaglutide
11 Marketing, Distributors and Customer
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Semaglutide Distributors
11.3 Semaglutide Customer
12 World Forecast Review for Semaglutide by Geographic Region
12.1 Global Semaglutide Market Size Forecast by Region
12.1.1 Global Semaglutide Forecast by Region (2023-2028)
12.1.2 Global Semaglutide Annual Revenue Forecast by Region (2023-2028)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Semaglutide Forecast by Type
12.7 Global Semaglutide Forecast by Application
13 Key Players Analysis
13.1 Novo Nordisk
13.1.1 Novo Nordisk Company Information
13.1.2 Novo Nordisk Semaglutide Product Offered
13.1.3 Novo Nordisk Semaglutide Sales, Revenue, Price and Gross Margin (2020-2022)
13.1.4 Novo Nordisk Main Business Overview
13.1.5 Novo Nordisk Latest Developments
14 Research Findings and Conclusion
Table 1. Semaglutide Annual Sales CAGR by Geographic Region (2017, 2022 & 2028) & ($ millions)
Table 2. Semaglutide Annual Sales CAGR by Country/Region (2017, 2022 & 2028) & ($ millions)
Table 3. Major Players of Injection
Table 4. Major Players of Oral
Table 5. Global Semaglutide Sales by Type (2017-2022) & (K Units)
Table 6. Global Semaglutide Sales Market Share by Type (2017-2022)
Table 7. Global Semaglutide Revenue by Type (2017-2022) & ($ million)
Table 8. Global Semaglutide Revenue Market Share by Type (2017-2022)
Table 9. Global Semaglutide Sale Price by Type (2017-2022) & (USD/Unit)
Table 10. Global Semaglutide Sales by Application (2017-2022) & (K Units)
Table 11. Global Semaglutide Sales Market Share by Application (2017-2022)
Table 12. Global Semaglutide Revenue by Application (2017-2022)
Table 13. Global Semaglutide Revenue Market Share by Application (2017-2022)
Table 14. Global Semaglutide Sale Price by Application (2017-2022) & (USD/Unit)
Table 15. Global Semaglutide Sales by Company (2020-2022) & (K Units)
Table 16. Global Semaglutide Sales Market Share by Company (2020-2022)
Table 17. Global Semaglutide Revenue by Company (2020-2022) ($ Millions)
Table 18. Global Semaglutide Revenue Market Share by Company (2020-2022)
Table 19. Global Semaglutide Sale Price by Company (2020-2022) & (USD/Unit)
Table 20. Key Manufacturers Semaglutide Producing Area Distribution and Sales Area
Table 21. Players Semaglutide Products Offered
Table 22. Semaglutide Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
Table 23. New Products and Potential Entrants
Table 24. Mergers & Acquisitions, Expansion
Table 25. Global Semaglutide Sales by Geographic Region (2017-2022) & (K Units)
Table 26. Global Semaglutide Sales Market Share Geographic Region (2017-2022)
Table 27. Global Semaglutide Revenue by Geographic Region (2017-2022) & ($ millions)
Table 28. Global Semaglutide Revenue Market Share by Geographic Region (2017-2022)
Table 29. Global Semaglutide Sales by Country/Region (2017-2022) & (K Units)
Table 30. Global Semaglutide Sales Market Share by Country/Region (2017-2022)
Table 31. Global Semaglutide Revenue by Country/Region (2017-2022) & ($ millions)
Table 32. Global Semaglutide Revenue Market Share by Country/Region (2017-2022)
Table 33. Americas Semaglutide Sales by Country (2017-2022) & (K Units)
Table 34. Americas Semaglutide Sales Market Share by Country (2017-2022)
Table 35. Americas Semaglutide Revenue by Country (2017-2022) & ($ Millions)
Table 36. Americas Semaglutide Revenue Market Share by Country (2017-2022)
Table 37. Americas Semaglutide Sales by Type (2017-2022) & (K Units)
Table 38. Americas Semaglutide Sales Market Share by Type (2017-2022)
Table 39. Americas Semaglutide Sales by Application (2017-2022) & (K Units)
Table 40. Americas Semaglutide Sales Market Share by Application (2017-2022)
Table 41. APAC Semaglutide Sales by Region (2017-2022) & (K Units)
Table 42. APAC Semaglutide Sales Market Share by Region (2017-2022)
Table 43. APAC Semaglutide Revenue by Region (2017-2022) & ($ Millions)
Table 44. APAC Semaglutide Revenue Market Share by Region (2017-2022)
Table 45. APAC Semaglutide Sales by Type (2017-2022) & (K Units)
Table 46. APAC Semaglutide Sales Market Share by Type (2017-2022)
Table 47. APAC Semaglutide Sales by Application (2017-2022) & (K Units)
Table 48. APAC Semaglutide Sales Market Share by Application (2017-2022)
Table 49. Europe Semaglutide Sales by Country (2017-2022) & (K Units)
Table 50. Europe Semaglutide Sales Market Share by Country (2017-2022)
Table 51. Europe Semaglutide Revenue by Country (2017-2022) & ($ Millions)
Table 52. Europe Semaglutide Revenue Market Share by Country (2017-2022)
Table 53. Europe Semaglutide Sales by Type (2017-2022) & (K Units)
Table 54. Europe Semaglutide Sales Market Share by Type (2017-2022)
Table 55. Europe Semaglutide Sales by Application (2017-2022) & (K Units)
Table 56. Europe Semaglutide Sales Market Share by Application (2017-2022)
Table 57. Middle East & Africa Semaglutide Sales by Country (2017-2022) & (K Units)
Table 58. Middle East & Africa Semaglutide Sales Market Share by Country (2017-2022)
Table 59. Middle East & Africa Semaglutide Revenue by Country (2017-2022) & ($ Millions)
Table 60. Middle East & Africa Semaglutide Revenue Market Share by Country (2017-2022)
Table 61. Middle East & Africa Semaglutide Sales by Type (2017-2022) & (K Units)
Table 62. Middle East & Africa Semaglutide Sales Market Share by Type (2017-2022)
Table 63. Middle East & Africa Semaglutide Sales by Application (2017-2022) & (K Units)
Table 64. Middle East & Africa Semaglutide Sales Market Share by Application (2017-2022)
Table 65. Key Market Drivers & Growth Opportunities of Semaglutide
Table 66. Key Market Challenges & Risks of Semaglutide
Table 67. Key Industry Trends of Semaglutide
Table 68. Semaglutide Raw Material
Table 69. Key Suppliers of Raw Materials
Table 70. Semaglutide Distributors List
Table 71. Semaglutide Customer List
Table 72. Global Semaglutide Sales Forecast by Region (2023-2028) & (K Units)
Table 73. Global Semaglutide Sales Market Forecast by Region
Table 74. Global Semaglutide Revenue Forecast by Region (2023-2028) & ($ millions)
Table 75. Global Semaglutide Revenue Market Share Forecast by Region (2023-2028)
Table 76. Americas Semaglutide Sales Forecast by Country (2023-2028) & (K Units)
Table 77. Americas Semaglutide Revenue Forecast by Country (2023-2028) & ($ millions)
Table 78. APAC Semaglutide Sales Forecast by Region (2023-2028) & (K Units)
Table 79. APAC Semaglutide Revenue Forecast by Region (2023-2028) & ($ millions)
Table 80. Europe Semaglutide Sales Forecast by Country (2023-2028) & (K Units)
Table 81. Europe Semaglutide Revenue Forecast by Country (2023-2028) & ($ millions)
Table 82. Middle East & Africa Semaglutide Sales Forecast by Country (2023-2028) & (K Units)
Table 83. Middle East & Africa Semaglutide Revenue Forecast by Country (2023-2028) & ($ millions)
Table 84. Global Semaglutide Sales Forecast by Type (2023-2028) & (K Units)
Table 85. Global Semaglutide Sales Market Share Forecast by Type (2023-2028)
Table 86. Global Semaglutide Revenue Forecast by Type (2023-2028) & ($ Millions)
Table 87. Global Semaglutide Revenue Market Share Forecast by Type (2023-2028)
Table 88. Global Semaglutide Sales Forecast by Application (2023-2028) & (K Units)
Table 89. Global Semaglutide Sales Market Share Forecast by Application (2023-2028)
Table 90. Global Semaglutide Revenue Forecast by Application (2023-2028) & ($ Millions)
Table 91. Global Semaglutide Revenue Market Share Forecast by Application (2023-2028)
Table 92. Novo Nordisk Basic Information, Semaglutide Manufacturing Base, Sales Area and Its Competitors
Table 93. Novo Nordisk Semaglutide Product Offered
Table 94. Novo Nordisk Semaglutide Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)
Table 95. Novo Nordisk Main Business
Table 96. Novo Nordisk Latest Developments
List of Figures
Figure 1. Picture of Semaglutide
Figure 2. Semaglutide Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Semaglutide Sales Growth Rate 2017-2028 (K Units)
Figure 7. Global Semaglutide Revenue Growth Rate 2017-2028 ($ Millions)
Figure 8. Semaglutide Sales by Region (2021 & 2028) & ($ millions)
Figure 9. Product Picture of Injection
Figure 10. Product Picture of Oral
Figure 11. Global Semaglutide Sales Market Share by Type in 2021
Figure 12. Global Semaglutide Revenue Market Share by Type (2017-2022)
Figure 13. Semaglutide Consumed in Hospital
Figure 14. Global Semaglutide Market: Hospital (2017-2022) & (K Units)
Figure 15. Semaglutide Consumed in Clinic
Figure 16. Global Semaglutide Market: Clinic (2017-2022) & (K Units)
Figure 17. Global Semaglutide Sales Market Share by Application (2017-2022)
Figure 18. Global Semaglutide Revenue Market Share by Application in 2021
Figure 19. Semaglutide Revenue Market by Company in 2021 ($ Million)
Figure 20. Global Semaglutide Revenue Market Share by Company in 2021
Figure 21. Global Semaglutide Sales Market Share by Geographic Region (2017-2022)
Figure 22. Global Semaglutide Revenue Market Share by Geographic Region in 2021
Figure 23. Global Semaglutide Sales Market Share by Region (2017-2022)
Figure 24. Global Semaglutide Revenue Market Share by Country/Region in 2021
Figure 25. Americas Semaglutide Sales 2017-2022 (K Units)
Figure 26. Americas Semaglutide Revenue 2017-2022 ($ Millions)
Figure 27. APAC Semaglutide Sales 2017-2022 (K Units)
Figure 28. APAC Semaglutide Revenue 2017-2022 ($ Millions)
Figure 29. Europe Semaglutide Sales 2017-2022 (K Units)
Figure 30. Europe Semaglutide Revenue 2017-2022 ($ Millions)
Figure 31. Middle East & Africa Semaglutide Sales 2017-2022 (K Units)
Figure 32. Middle East & Africa Semaglutide Revenue 2017-2022 ($ Millions)
Figure 33. Americas Semaglutide Sales Market Share by Country in 2021
Figure 34. Americas Semaglutide Revenue Market Share by Country in 2021
Figure 35. United States Semaglutide Revenue Growth 2017-2022 ($ Millions)
Figure 36. Canada Semaglutide Revenue Growth 2017-2022 ($ Millions)
Figure 37. Mexico Semaglutide Revenue Growth 2017-2022 ($ Millions)
Figure 38. Brazil Semaglutide Revenue Growth 2017-2022 ($ Millions)
Figure 39. APAC Semaglutide Sales Market Share by Region in 2021
Figure 40. APAC Semaglutide Revenue Market Share by Regions in 2021
Figure 41. China Semaglutide Revenue Growth 2017-2022 ($ Millions)
Figure 42. Japan Semaglutide Revenue Growth 2017-2022 ($ Millions)
Figure 43. South Korea Semaglutide Revenue Growth 2017-2022 ($ Millions)
Figure 44. Southeast Asia Semaglutide Revenue Growth 2017-2022 ($ Millions)
Figure 45. India Semaglutide Revenue Growth 2017-2022 ($ Millions)
Figure 46. Australia Semaglutide Revenue Growth 2017-2022 ($ Millions)
Figure 47. Europe Semaglutide Sales Market Share by Country in 2021
Figure 48. Europe Semaglutide Revenue Market Share by Country in 2021
Figure 49. Germany Semaglutide Revenue Growth 2017-2022 ($ Millions)
Figure 50. France Semaglutide Revenue Growth 2017-2022 ($ Millions)
Figure 51. UK Semaglutide Revenue Growth 2017-2022 ($ Millions)
Figure 52. Italy Semaglutide Revenue Growth 2017-2022 ($ Millions)
Figure 53. Russia Semaglutide Revenue Growth 2017-2022 ($ Millions)
Figure 54. Middle East & Africa Semaglutide Sales Market Share by Country in 2021
Figure 55. Middle East & Africa Semaglutide Revenue Market Share by Country in 2021
Figure 56. Egypt Semaglutide Revenue Growth 2017-2022 ($ Millions)
Figure 57. South Africa Semaglutide Revenue Growth 2017-2022 ($ Millions)
Figure 58. Israel Semaglutide Revenue Growth 2017-2022 ($ Millions)
Figure 59. Turkey Semaglutide Revenue Growth 2017-2022 ($ Millions)
Figure 60. GCC Country Semaglutide Revenue Growth 2017-2022 ($ Millions)
Figure 61. Manufacturing Cost Structure Analysis of Semaglutide in 2021
Figure 62. Manufacturing Process Analysis of Semaglutide
Figure 63. Industry Chain Structure of Semaglutide
Figure 64. Channels of Distribution
Figure 65. Distributors Profiles
Similar Reports
The United States pneumococcal & meningococcal vaccines market is set to surpass US$ 7.5 Million by the year end of 2025. “United States Pneumococcal & Meningococcal Vaccines Market by Company Profile, Deals Type, Brand Analysis, Share, Key Trends & Opportunities to 2025” presents an in–depth assessment of the United States pneumococcal & meningococcal vaccines market dynamics, opportunitie...
- Publish Date: June 24, 2019
- $1050
The global human immunodeficiency virus (HIV) drugs market size is expected to surpass US$ 30 billion by 2025. “Global Human Immunodeficiency Virus (HIV) Drugs Market 2019 – 2025: Top 22 Drugs Analysis, Key Trends, Players and Forecasts” presents an in-depth assessment of the global human immunodeficiency virus (HIV) drugs market dynamics, opportunities, future roadmap, competitive landscap...
- Publish Date: February 18, 2019
- $1290
The global 50 blockbuster drugs market size is estimated to reach a value of US$ 292 billion by 2025. ‘’Global Blockbuster Drugs Market 2015 - 2025: Top 50 Drugs Analysis, Deal Trends, Players and Forecasts” presents an in-depth assessment of the global blockbuster drugs market dynamics, opportunities, future roadmap, competitive landscape and discusses major trends. The report offers the m...
- Publish Date: December 11, 2018
- $1390
